NCT06359756Completed
Ischemic Postconditioning in Carotid Surgery
Ischemic Postconditioning in Prevention of Brain Damage After Carotid Surgery - a Clinical Trial for Vascular Evaluation
Source: ClinicalTrials.gov · Last updated 27 Mar 2026
Brief summary (registry, in English)
Analyzing changes in cerebral oximetry, transcranial Doppler and biomarkers of neuronal ischemic injury and blood-brain barrier integrity assessing the safety and efficacy of ischemic postconditioning in carotid surgery (IPCT).
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 6 Apr 2024
- Start date
- 1 Sept 2023
- Primary completion date
- 1 Jan 2026
- Lead sponsor
- Institute for Cardiovascular Diseases Dedinje
- Diseases
- Stroke
- NCT number
- NCT06359756
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 1 Sept 2023 to the primary completion date, 1 Jan 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- "major surgery" in the last 6 months
- previous brain trauma or surgery
Other illness
- malignant diseases
- epilepsy
Other
- urgent carotid endarterectomy
- carotid restenosis
Who the study is looking for
- unilateral carotid artery stenosis \>90%
- bilateral stenosis \>80%
- unilateral stenosis \>80% with contralateral occlusion/subocclusion
Age in the registry: 50 years to 85 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Institute for Cardiovascular Diseases Dedinje Coordinator of this site? Confirm its status | Belgrade | Serbia | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.